COMMUNIQUÉS West-GlobeNewswire

Exalenz Bioscience’s BreathID® Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
13/03/2018
MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN ), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]
Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer Award
13/03/2018
MOORESTOWN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc ., (“TRHC”) (NASDAQ: TRHC ) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has been named the 2018 [...]
Precipio Settles Lawsuit with Crede Capital
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it has settled its lawsuit with Crede Capital Group LLC, restructuring the final [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
13/03/2018
MINNEAPOLIS, March 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]
Hydropothecary bolsters management team in preparation for recreational cannabis
13/03/2018
GATINEAU, Quebec, March 13, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX Venture:THCX) (“Hydropothecary”) is pleased to announce the addition of three new members to its management team. Roch [...]
Hydropothecary renforce son équipe de direction en vue de la légalisation du cannabis à fins récréatives
13/03/2018
GATINEAU, Québec, 13 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary ») a le plaisir d’annoncer l’arrivée de trois nouveaux cadres dans son équipe de direction. Roch [...]
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018
13/03/2018
Phoenix, March 13, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly [...]
Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
13/03/2018
TUSTIN, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin
13/03/2018
13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ID Kit and platform begin Decentralised molecular HCV assays shipped to Africa genedrive plc (AIM: GDR), the near patient [...]
Healthwise and GetWellNetwork Partner to Deliver Award-Winning Health Education
13/03/2018
BOISE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- Healthwise and GetWellNetwork ® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over [...]
CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Tauriga Sciences Inc. Purchases Shares of Virginia Based NASDAQ Listed Company Focused on Nuclear Fuel Technology Development
13/03/2018
NEW YORK, NY , March 13, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Caladrius Biosciences Doses First Patient with CLBS12 in Phase 2 Critical Limb Ischemia Trial in Japan
13/03/2018
BASKING RIDGE, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Rexahn Pharmaceuticals to Present at Two Upcoming Conferences
13/03/2018
B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on March 16 Oppenheimer 28th Annual Healthcare Conference on March 21 ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Rexahn [...]
Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Association’s 78th Scientific Sessions
13/03/2018
WESTLAKE VILLAGE, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]
Avinger Provides Update on U.S. Intellectual Property Portfolio
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced three recent additions to its U.S [...]
RavenQuest Completes Final Tranche of Financing
13/03/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast
13/03/2018
Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time. NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]

Pages